Kaleidoscope Raises $6M Seed Financing Co-Led by Hummingbird Ventures and Dimension
September 28, 2022
NEW YORK -- Kaleidoscope, pioneering an operating system to accelerate research team performance, today announced the completion of a $6M seed financing round, co-led by Hummingbird Ventures and Dimension, with participation from Caffeinated Capital, SV Angel, Hawktail, and individual investors. The funding will be used to invest in product development and team expansion, with a [...]
Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences
September 27, 2022
Newly Created Form Bio Raises $30M Series A Funding Led by JAZZ Venture Partners to empower life scientists with a complete platform for managing large datasets, executing verified workflows, visualizing results and collaborating with their peers - bridging the gap between data and discovery. DALLAS, TX - Colossal Biosciences, the de-extinction company behind the woolly mammoth and [...]
September 27, 2022
Approval also marks the second NGS-based companion diagnostic to identify RET-fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC) CARLSBAD, Calif. -- The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET-fusion positive locally [...]
Alpha Resources Expands Product Offerings
September 27, 2022
Adds to ICP-MS Supplies Compatible with Leading OEM equipment Stevensville, Michigan – Alpha Resources LLC, the leading aftermarket supplier of consumables and reference materials, has expanded their Thermo Fisher Scientific® compatible products to include supplies for inductively coupled plasma mass spectrometry (ICP-MS) analysis. In-stock supplies include both sample cone and skimmer cone options compatible with [...]
BD Launches State-of-the-Art Cloud Software Solution to Streamline Flow Cytometry Research
September 27, 2022
New BD® Research Cloud provides scientists with an integrated ecosystem that allows for optimizing panel design, collaboration and analysis FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher quality experiments [...]
September 27, 2022
The expanded facility will concentrate, into a single building, full activity of the company aimed at development of solutions covering all phases of a complete and equipped new critical pharmaceutical installation Telstar will be expanding its facilities with the construction of three additional modules, adjacent to the building where the headquarters are currently located. The [...]
PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat Analysis
September 27, 2022
Analysis Method Supports Research on the Genetic Causes of Common Diseases MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of a new computational analysis method for profiling more than a million tandem repeats (TRs) across the human genome using PacBio's native long-read HiFi sequencing data. The Tandem [...]
September 27, 2022
SACRAMENTO, Calif. -- Eurofins Sacramento, part of the Eurofins (Paris:ERF) network of companies in the US, in collaboration with SCIEX USA, successfully achieved the analytical challenge of detecting the 2022 interim Health Advisory Levels (HALs) of 4ppq (parts per quadrillion) for PFOA and 20ppq for PFOS, as established by the US EPA. The drinking water [...]
September 27, 2022
The PIPseq™ T100 kits enable any researcher to easily perform large, complex single-cell transcriptomic applications in a single reaction with no expensive capital equipment Watertown, MA – Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces the launch of a novel 100,000 cell product for 3′ [...]
Neogen Announces CFO Transition
September 27, 2022
LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that Steve Quinlan, the company’s Chief Financial Officer, has announced his intent to retire effective May 31, 2023, at the conclusion of the company’s fiscal year. Quinlan has served as Neogen’s CFO since 2011, leading the company through more than 30 acquisitions, including the company’s recent acquisition [...]
